Regulations established in March 1999 (21 CFR 206.66) define format and content requirements for the labeling of over-the-counter (OTC)drug products. Specifically, these requirements apply to labeling within the Drug Facts panel required for all OTC drug products (i.e., "Drug Facts" labeling). All OTC drug products except sunscreens have been required to comply with the labeling requirements set forth in 21 CFR 206.66 since June 2005. Complying with these regulations imposes a burden on the manufacturers of new OTC drug products. The burden consists of preparing new labeling for these products that complies with the Drug Facts labeling requirements
The previous burden estimate in 2011 was 14,303 hours. The decrease in burden to 11,523 (-2,780) hours is mostly attributed to a decrease in the number of manufacturers of sunscreen drug products and a corresponding decrease in the number of total annual burden for manufacturers of new products marketed under NDA, ANDAs, or OTC drug monographs used for the estimates under section 201.66(c) and (d). In addition, the respondents of sunscreen drug products has decreased from the estimate in 2011 from 400 to 20. Conversely, the hours per response increased from 9500 to 720.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.